Amy Andreucci

563 total citations
10 papers, 388 citations indexed

About

Amy Andreucci is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Amy Andreucci has authored 10 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Genetics. Recurrent topics in Amy Andreucci's work include NF-κB Signaling Pathways (3 papers), Neurogenetic and Muscular Disorders Research (2 papers) and T-cell and B-cell Immunology (2 papers). Amy Andreucci is often cited by papers focused on NF-κB Signaling Pathways (3 papers), Neurogenetic and Muscular Disorders Research (2 papers) and T-cell and B-cell Immunology (2 papers). Amy Andreucci collaborates with scholars based in United States. Amy Andreucci's co-authors include Jeffrey A. Ucran, Ravindra Kumar, Dianne Sako, Jasbir Seehra, Asya V. Grinberg, Barbara S. Nikolajczyk, Kathryn Underwood, Kathleen Tomkinson, Travis Monnell and Erik Martı́nez-Hackert and has published in prestigious journals such as Journal of Biological Chemistry, Neurology and Biochemical and Biophysical Research Communications.

In The Last Decade

Amy Andreucci

9 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Andreucci United States 7 264 92 64 44 39 10 388
Yusheng Wang China 13 276 1.0× 33 0.4× 58 0.9× 28 0.6× 52 1.3× 36 527
Simona Donadei Italy 9 481 1.8× 118 1.3× 19 0.3× 54 1.2× 60 1.5× 12 561
Xiaohuan Gao United States 9 303 1.1× 61 0.7× 31 0.5× 57 1.3× 54 1.4× 15 538
Justin Williams Canada 8 187 0.7× 62 0.7× 18 0.3× 20 0.5× 31 0.8× 9 377
Takeo Higashikata Japan 8 169 0.6× 25 0.3× 49 0.8× 15 0.3× 33 0.8× 17 332
Yaru Su China 10 253 1.0× 33 0.4× 24 0.4× 20 0.5× 52 1.3× 19 387
Bahram Khadivi United States 4 247 0.9× 62 0.7× 14 0.2× 27 0.6× 31 0.8× 5 484
Jenni Virta Finland 12 127 0.5× 38 0.4× 106 1.7× 17 0.4× 34 0.9× 31 390
S. P. Bidey United Kingdom 13 173 0.7× 63 0.7× 39 0.6× 18 0.4× 11 0.3× 27 493

Countries citing papers authored by Amy Andreucci

Since Specialization
Citations

This map shows the geographic impact of Amy Andreucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Andreucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Andreucci more than expected).

Fields of papers citing papers by Amy Andreucci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Andreucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Andreucci. The network helps show where Amy Andreucci may publish in the future.

Co-authorship network of co-authors of Amy Andreucci

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Andreucci. A scholar is included among the top collaborators of Amy Andreucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Andreucci. Amy Andreucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Liu, Yuanjing, Amy Andreucci, Naoki Iwamoto, et al.. (2022). Preclinical evaluation of WVE-004, an investigational stereopure oligonucleotide for the treatment of C9orf72-associated ALS or FTD. Molecular Therapy — Nucleic Acids. 28. 558–570. 36 indexed citations
2.
Deprey, Kirsten, Marjoke F. Debets, Kirstin B. VanderWall, et al.. (2022). Quantitative Measurement of Cytosolic and Nuclear Penetration of Oligonucleotide Therapeutics. ACS Chemical Biology. 17(2). 348–360. 18 indexed citations
3.
Liu, Yuanjing, Amy Andreucci, Naoki Iwamoto, et al.. (2021). WVE-004, an investigational stereopure antisense oligonucleotide for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) (2302). Neurology. 96(15_supplement). 5 indexed citations
4.
Schmidt, Michael M., Sharon A. Townson, Amy Andreucci, et al.. (2013). Crystal Structure of an HSA/FcRn Complex Reveals Recycling by Competitive Mimicry of HSA Ligands at a pH-Dependent Hydrophobic Interface. Structure. 21(11). 1966–1978. 92 indexed citations
5.
Koncarevic, Alan, Shingo Kajimura, Milton Cornwall-Brady, et al.. (2012). A Novel Therapeutic Approach to Treating Obesity through Modulation of TGFβ Signaling. Endocrinology. 153(7). 3133–3146. 86 indexed citations
6.
Sako, Dianne, Asya V. Grinberg, June Liu, et al.. (2010). Characterization of the Ligand Binding Functionality of the Extracellular Domain of Activin Receptor Type IIB. Journal of Biological Chemistry. 285(27). 21037–21048. 113 indexed citations
7.
McDevit, Daniel C., et al.. (2003). HMGA1 Co-activates Transcription in B Cells through Indirect Association with DNA. Journal of Biological Chemistry. 278(43). 42106–42114. 18 indexed citations
8.
Andreucci, Amy, et al.. (2002). Dominant-Negative HMGA1 Blocks μ Enhancer Activation through a Novel Mechanism. Biochemical and Biophysical Research Communications. 292(2). 427–433. 3 indexed citations
9.
Lewis, Robert T., Amy Andreucci, & Barbara S. Nikolajczyk. (2001). PU.1-mediated Transcription Is Enhanced by HMG-I(Y)-dependent Structural Mechanisms. Journal of Biological Chemistry. 276(12). 9550–9557. 17 indexed citations
10.
Marcato, P. S., et al.. (1970). Nephropathy in calves affected with chronic rumenitis of dietary origin.. 2. 371–393.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026